Tuesday 13 October 2026
Export NUS’s income statement to Excel — free account
Nu Skin Enterprises, Inc.
NUS Consumer Defensive Household & Personal Products
Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.87
0.13
+2.74%
Follow NUS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
18.83 | 27.98 | 27.63 | 13.13 | 14.73 | 17.38 | 20.12 | 112.89 | 0.00 | 2.97 |
Piotroski F-Score |
7 | 7 | 5 | 6 | 6 | 6 | 5 | 5 | 4 | 7 |
Altman Z-Score |
5.71 | 6.11 | 5.88 | 5.02 | 4.90 | 4.98 | 4.55 | 3.46 | 2.92 | 3.78 |
P/S ratio |
1.22 | 1.59 | 1.26 | 0.94 | 1.11 | 0.95 | 0.95 | 0.51 | 0.20 | 0.32 |
Altman Z″-Score (non-manufacturers) |
6.76 | 6.66 | 6.39 | 6.65 | 6.04 | 6.24 | 6.34 | 5.78 | 5.02 | 7.36 |
P/FCF ratio |
12.01 | 14.94 | 25.56 | 20.34 | 9.06 | 34.91 | 43.11 | 16.79 | 4.88 | 10.31 |
Beneish M-Score |
(3.12) | (2.91) | (2.14) | (2.36) | (2.75) | (2.76) | (2.20) | (2.47) | (3.43) | (2.35) |
P/Operating CF |
30.08 | 24.67 | 38.07 | 45.59 | 30.17 | 23.26 | 82.77 | 18.65 | 13.27 | 28.53 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 70 |
P/B ratio |
4.07 | 5.14 | 4.33 | 2.60 | 3.19 | 2.79 | 2.35 | 1.23 | 0.53 | 0.59 |
Price to Tangible BV |
5.57 | 6.94 | 6.83 | 3.80 | 4.75 | 4.05 | 3.38 | 1.99 | 0.69 | 0.70 |
EV/Sales |
1.25 | 1.57 | 1.28 | 0.95 | 1.07 | 0.95 | 1.00 | 0.63 | 0.31 | 0.31 |
EV/EBITDA |
9.06 | 10.32 | 10.55 | 6.66 | 8.35 | 8.28 | 12.20 | 10.45 | 0.00 | 3.89 |
EV/Operating CF |
9.99 | 11.80 | 16.85 | 12.89 | 7.30 | 18.14 | 20.70 | 10.50 | 4.81 | 5.71 |
EV/FCF |
12.23 | 14.73 | 25.81 | 20.50 | 8.78 | 35.20 | 45.64 | 20.70 | 7.67 | 9.97 |
Quick Ratio |
1.00 | 1.05 | 1.03 | 1.11 | 0.90 | 0.75 | 0.91 | 0.99 | 0.84 | 1.06 |
Current Ratio |
1.79 | 1.74 | 1.82 | 2.07 | 1.66 | 1.65 | 2.12 | 2.13 | 1.82 | 2.08 |
Net Debt/EBITDA |
0.16 | (0.14) | 0.10 | 0.05 | (0.27) | 0.07 | 0.68 | 1.97 | (2.39) | (0.13) |
Debt/Assets |
28.28% | 24.44% | 25.40% | 20.46% | 17.14% | 19.74% | 22.10% | 27.81% | 26.80% | 15.95% |
Debt/Equity |
0.63 | 0.55 | 0.55 | 0.41 | 0.38 | 0.41 | 0.45 | 0.61 | 0.60 | 0.28 |
Asset Turnover |
1.48 | 1.49 | 1.63 | 1.40 | 1.39 | 1.40 | 1.19 | 1.09 | 1.06 | 1.03 |
Operating CF/Net income |
1.92 | 2.34 | 1.66 | 1.03 | 1.98 | 0.96 | 1.03 | 13.80 | (0.76) | 0.50 |
Capex/Depreciation |
(0.69) | (0.84) | (0.85) | (0.86) | (0.86) | (0.90) | (0.81) | (0.82) | (0.60) | (0.66) |
Interest Coverage |
— | — | — | — | — | — | 8.22 | 1.89 | (5.74) | 4.71 |
| 19.21% | 18.91% | 16.40% | 20.95% | 21.63% | 16.30% | 11.58% | 1.00% | (19.90%) | 22.00% | |
| 9.60% | 8.45% | 7.42% | 10.02% | 10.27% | 7.62% | 5.62% | 0.47% | (8.95%) | 11.15% | |
ROIC |
20.26% | 26.19% | 18.49% | 18.71% | 19.98% | 15.65% | 6.78% | 2.85% | (11.18%) | 5.21% |
Return on Tangible Assets |
18.83% | 16.28% | 14.79% | 20.73% | 23.10% | 18.48% | 12.39% | 1.07% | (23.58%) | 24.23% |
Average Days of Receivables |
5.16 | 5.32 | 7.26 | 7.60 | 8.96 | 5.59 | 7.77 | 10.88 | 10.70 | 9.72 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
66.86% | 65.93% | 64.70% | 64.93% | 64.54% | 64.35% | 64.49% | 65.47% | 65.30% | 63.33% |
Intangible Assets out of Total Assets |
0.12 | 0.11 | 0.17 | 0.16 | 0.15 | 0.15 | 0.15 | 0.17 | 0.11 | 0.09 |
Share Based Compensation of Revenue |
0.40% | 0.85% | 0.99% | 0.41% | 0.93% | 0.86% | 0.56% | 0.79% | 0.86% | 1.62% |
Graham Net Nets |
(0.04) | (0.03) | (0.03) | (0.07) | (0.06) | (0.05) | (0.08) | (0.28) | (0.81) | (0.11) |
Graham Number |
26.43 | 27.12 | 26.61 | 33.27 | 37.78 | 34.57 | 29.12 | 8.18 | 0.00 | 34.51 |
Earnings Yield |
5.31% | 3.57% | 3.62% | 7.61% | 6.79% | 5.75% | 4.97% | 0.89% | (42.82%) | 33.68% |
Free Cash Flow Yield |
8.33% | 6.70% | 3.91% | 4.92% | 11.04% | 2.86% | 2.32% | 5.95% | 20.50% | 9.70% |
Revenue per Share |
39.84 | 43.16 | 48.56 | 43.60 | 49.37 | 53.71 | 44.51 | 39.61 | 34.88 | 30.13 |
Operating CF per Share |
4.97 | 5.73 | 3.67 | 3.20 | 7.25 | 2.82 | 2.16 | 2.39 | 2.25 | 1.63 |
Capex per Share |
(0.91) | (1.14) | (1.28) | (1.19) | (1.22) | (1.37) | (1.18) | (1.18) | (0.84) | (0.70) |
Free Cash Flow per Share |
4.06 | 4.59 | 2.40 | 2.01 | 6.03 | 1.45 | 0.98 | 1.21 | 1.41 | 0.93 |
Cash per Share |
6.64 | 8.30 | 7.22 | 6.20 | 8.11 | 7.07 | 5.57 | 5.39 | 3.99 | 4.87 |
Shareholders Equity per Share |
11.98 | 13.34 | 14.17 | 15.77 | 17.10 | 18.19 | 17.95 | 16.53 | 13.12 | 16.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.98 | 13.34 | 14.17 | 15.77 | 17.10 | 18.19 | 17.95 | 16.53 | 13.12 | 16.34 |
Free Cash Flow |
225.04 | 242.40 | 132.37 | 111.86 | 315.32 | 72.97 | 49.01 | 60.15 | 70.16 | 46.01 |
Working Capital |
315.33 | 330.42 | 359.58 | 383.41 | 360.34 | 343.26 | 400.63 | 373.00 | 241.99 | 283.96 |
Capital Expenditures |
(50.22) | (60.16) | (70.37) | (66.07) | (63.82) | (68.61) | (59.06) | (58.49) | (41.58) | (34.28) |
Net Current Asset Value |
(95.64) | (107.49) | (113.34) | (153.55) | (159.61) | (120.76) | (163.81) | (284.79) | (278.86) | (52.37) |
EV/EBIT |
11.90 | 13.01 | 14.18 | 8.57 | 10.75 | 10.98 | 20.18 | 25.80 | 0.00 | 6.97 |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
11.69 | 13.19 | 14.05 | 8.51 | 11.09 | 10.89 | 19.06 | 20.93 | 0.00 | 7.21 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.16 | 0.15 | 0.18 | 0.17 | 0.16 | 0.17 | 0.16 | 0.16 | 0.18 | 0.14 |
Cash ROIC |
15.53% | 15.83% | 8.22% | 7.07% | 19.07% | 4.44% | 3.11% | 3.78% | 5.64% | 3.62% |
Accounts Receivable Turnover |
66.24 | 70.79 | 61.96 | 46.70 | 45.40 | 51.51 | 50.21 | 37.13 | 31.64 | 32.88 |
Accounts Payable Turnover |
14.28 | 10.96 | 12.95 | 13.43 | 12.52 | 11.63 | 12.14 | 12.61 | 14.11 | 14.86 |
Inventory Turnover |
1.94 | 1.99 | 2.31 | 2.03 | 2.23 | 1.89 | 1.69 | 1.95 | 2.34 | 2.46 |
Average Days of Payables |
30.09 | 36.60 | 27.41 | 24.47 | 36.71 | 27.02 | 31.22 | 25.72 | 23.14 | 21.06 |
Days of Inventory on Hand |
182.29 | 184.26 | 170.27 | 173.20 | 174.37 | 216.19 | 200.28 | 167.02 | 126.20 | 143.70 |
Average Receivables |
33.33 | 32.20 | 43.24 | 51.83 | 56.87 | 52.33 | 44.33 | 53.03 | 54.74 | 45.16 |
Average Payables |
35.05 | 45.80 | 48.98 | 43.30 | 52.58 | 58.08 | 51.98 | 48.54 | 39.00 | 30.53 |
Average Inventory |
257.60 | 251.70 | 274.64 | 285.86 | 295.13 | 357.15 | 373.06 | 313.08 | 235.11 | 184.44 |
Average Assets |
1,489.94 | 1,531.96 | 1,642.16 | 1,731.73 | 1,863.04 | 1,931.78 | 1,863.73 | 1,814.80 | 1,638.77 | 1,437.11 |
Average Common Equity |
744.85 | 684.33 | 743.23 | 828.58 | 884.78 | 903.52 | 905.03 | 859.63 | 736.71 | 728.35 |
Columns are period end dates